BCL2L14 and colorectal carcinoma: In stage I CRC, levels of both BCL-G transcripts decreased in cancerous tissue compared with patient-matched uninvolved epithelium, and this low tumoural BCL-GS/L expression remained unchanged through clinical grades II–IV (Fig. 1d).